The Second ECMM Workshop "Pathogenesis and Antifungal Management of Opportunistic Fungal Diseases" was held in Milan, Italy on September 25, 2010 during 10th Congress of Italian Society of Mycologists (FIMUA). The workshop included 3 sessions on pathogenesis and therapy of invasive and opportunistic mycoses, including topics of antifungal drug resistance and strategies for neutropenic and ICU patients. Before the workshop, 2010 ECMM Council meeting took place.
PATHOGENESIS AND ANTIFUNGAL MANAGEMENT OF OPPORTUNISTIC FUNGAL DISEASES
SATURDAY 25 SEPTEMBER 2010
09.00-11.00
Advances in the Understanding of the Pathogenesis of Opportinistic Fungal Diseases
Chaired by: Jacques Meis, NL and Esther Segal, IL
| Candidosis Cryptococcosis Aspergillosis Zygomycosis |
Esther Segal, IL Olivier Lortholary, FR Luigina Romani, IT George Petrikkos, GR |
11.00-11.30
Poster vision & Coffee
11.30-13.00
Therapy 1
Chaired by: Emmanuel Roilides, GR and Cornelia Lass-Floerl, AT
| What have we learned about systemic antifungals currently available on the market? | George Maschmeyer, DE |
The pharmacologist’s remarks |
Andrea Novelli, IT |
| Antifungal drug resistance: the impact in clinical management | Francesco Barchiesi, IT |
| Antifungal drug resistance: towards the most reliable detection method | Cornelia Lass-Floerl, AT |
13.00-14.00
Lunch
14.00-16.30
Therapy 2
Chaired by: Bertrand Dupont, FR and Katrien Lagrou, BE
| Can diagnostics improve therapy? | Maiken Arendrup, DK |
| How can we prevent invasive fungal diseases? | Christopher C. Kibbler, UK |
| Strategies in antifungal therapy: the neutropenic patient | Claudio Viscoli, IT |
| Strategies in antifungal therapy: the ICU patient | Oscar Marchetti, C |